| Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence RP Mattick, J Kimber, C Breen, M Davoli Cochrane Database Syst Rev 2, 2008 | 3127* | 2008 |
| Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence RP Mattick, C Breen, J Kimber, M Davoli Cochrane database of systematic reviews, 2009 | 2430 | 2009 |
| Neonatal abstinence syndrome and high school performance JL Oei, E Melhuish, H Uebel, N Azzam, C Breen, L Burns, L Hilder, ... Pediatrics 139 (2), 2017 | 188 | 2017 |
| Reasons for rehospitalization in children who had neonatal abstinence syndrome H Uebel, IM Wright, L Burns, L Hilder, B Bajuk, C Breen, ME Abdel-Latif, ... Pediatrics 136 (4), e811-e820, 2015 | 131 | 2015 |
| Australian drug trends 2016 J Stafford, C Breen National Drug and Alcohol Research Centre, 2017 | 122 | 2017 |
| Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia L Degenhardt, E Black, C Breen, R Bruno, S Kinner, A Roxburgh, C Fry, ... Drug and Alcohol Review 25 (5), 403-412, 2006 | 102 | 2006 |
| Risk and benefit perceptions of party drug use B White, L Degenhardt, C Breen, R Bruno, J Newman, P Proudfoot Addictive behaviors 31 (1), 137-142, 2006 | 94 | 2006 |
| The recovery of online drug markets following law enforcement and other disruptions J Van Buskirk, R Bruno, T Dobbins, C Breen, L Burns, S Naicker, ... Drug and alcohol dependence 173, 159-162, 2017 | 93 | 2017 |
| AUSTRALIAN DRUG TRENDS 2006 Findings from the Illicit Drug Reporting System (IDRS) NDARC Monograph No. 60 S O’Brien, E Black, L Degenhardt, A Roxburgh, G Campbell, B De Graaff, ... Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2007 | 93* | 2007 |
| Adapting the Illicit Drug Reporting System (IDRS) to examine the feasibility of monitoring trends in the markets for ‘party drugs’ L Topp, C Breen, S Kaye, S Darke Drug and Alcohol Dependence 73 (2), 189-197, 2004 | 91 | 2004 |
| National evaluation of pharmacotherapies for opioid dependence: report of results and recommendations RP Mattick, E Digiusto, CM Doran, S O'Brien, M Shanahan, J Kimber, ... Sydney: National Drug and Alcohol Research Centre, 2001 | 87 | 2001 |
| Australian Drug Trends 2003. Findings of the Illicit Drug Reporting System (IDRS) C Breen, L Degenhardt, A Roxburgh, R Bruno, J Fetherston, R Jenkinson, ... University Of Tasmania, 2004 | 83 | 2004 |
| Counting Fetal Alcohol Spectrum Disorder in A ustralia: The evidence and the challenges L Burns, C Breen, C Bower, C O'Leary, EJ Elliott Drug and Alcohol Review 32 (5), 461-467, 2013 | 77 | 2013 |
| Drugs and the Internet J Van Buskirk, S Naicker, R Bruno, L Burns, C Breen, A Roxburgh Drugs and New Technologies (DNeT) Bulletins, 1-11, 2016 | 76 | 2016 |
| Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions CL Breen, SJ Harris, N Lintzeris, RP Mattick, L Hawken, J Bell, AJ Ritter, ... Drug and alcohol dependence 71 (1), 49-55, 2003 | 76 | 2003 |
| Alcohol use in pregnancy: prevalence and predictors in the L ongitudinal S tudy of a ustralian C hildren D Hutchinson, EA Moore, C Breen, L Burns, RP Mattick Drug and alcohol review 32 (5), 475-482, 2013 | 73 | 2013 |
| Alcohol use and risk taking among regular ecstasy users C Breen, L Degenhardt, S Kinner, R Bruno, R Jenkinson, A Matthews, ... Substance use & misuse 41 (8), 1095-1109, 2006 | 71 | 2006 |
| The effectiveness of community action in reducing risky alcohol consumption and harm: a cluster randomised controlled trial A Shakeshaft, C Doran, D Petrie, C Breen, A Havard, A Abudeen, ... PLoS medicine 11 (3), e1001617, 2014 | 70 | 2014 |
| Changes in patterns of drug use among injecting drug users following changes in the availability of heroin in New South Wales, Australia A Roxburgh, L Degenhardt, C Breen Drug and Alcohol Review 23 (3), 287-294, 2004 | 56 | 2004 |
| Adapting the IDRS methodology to monitor trends in party drug markets: Findings of a two-year Feasibility trial C Breen, L Topp, M Longo University of New South Wales, National Drug and Alcohol Research Centre, 2002 | 49 | 2002 |
